Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Follow-On Biologics Coding Tweaks Could Raise Savings By 30% – CBO

Executive Summary

Giving a follow-on biologic the same reimbursement code as its brand name counterpart would increase the savings from FOBs by 30 percent for the federal government's mandatory health care programs, the Congressional Budget Office estimates
Advertisement

Related Content

Biosimilars Would Have Medicare Parity With Innovators Under Reform Bill
Biosimilars Would Have Medicare Parity With Innovators Under Reform Bill
Biosimilars Would Have Reimbursement Parity With Innovators Under Health Reform Bill
Follow-on Biologics Savings Lower In Administration Budget Proposal
Follow-on Biologics Savings Lower In Administration Budget Proposal
Follow-on Biologics Savings Lower In Administration’s Budget Proposal
Medicare Coverage For FOBs: MedPAC Weighs Least Costly Alternative, Coding Options
Follow The Follow-On Money: Obama’s Budget Has Modest Biogeneric Savings
BIO Wants 14 Years Of Data Exclusivity For Biosimilars; Will Waxman Buy It?
Follow-on Biologics Get Modest Savings Score From CBO, Giving Legislation No Push
Advertisement
UsernamePublicRestriction

Register

PS050473

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel